Skip to main content
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Browse by collection
Archive
Authors
About
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Browse by collection
Archive
Authors
About
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 7, Issue 1
High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
XML
Short Report
High OX-40 expression in the tumor immune infiltrate is a favorable prognostic factor of overall survival in non-small cell lung cancer
Online download statistics by month:
Online download statistics by month: January 2020 to March 2024
Abstract
Full
Pdf
Jan 2020
15
15
0
Feb 2020
40
40
0
Mar 2020
69
69
1
Apr 2020
49
49
12
May 2020
44
44
16
Jun 2020
61
61
26
Jul 2020
41
41
37
Aug 2020
42
42
63
Sep 2020
39
39
40
Oct 2020
71
71
31
Nov 2020
48
48
28
Dec 2020
46
46
74
Jan 2021
67
67
36
Feb 2021
45
45
86
Mar 2021
56
56
30
Apr 2021
32
32
19
May 2021
57
57
38
Jun 2021
31
31
21
Jul 2021
33
33
19
Aug 2021
40
40
25
Sep 2021
46
46
32
Oct 2021
38
38
45
Nov 2021
34
34
32
Dec 2021
39
39
19
Jan 2022
49
54
18
Feb 2022
25
25
18
Mar 2022
26
28
16
Apr 2022
24
27
18
May 2022
44
48
26
Jun 2022
26
28
19
Jul 2022
31
32
13
Aug 2022
33
33
16
Sep 2022
30
30
24
Oct 2022
17
17
14
Nov 2022
31
33
25
Dec 2022
26
26
11
Jan 2023
19
19
14
Feb 2023
21
21
7
Mar 2023
13
15
10
Apr 2023
21
21
8
May 2023
12
12
6
Jun 2023
17
17
14
Jul 2023
18
18
18
Aug 2023
15
15
12
Sep 2023
18
18
5
Oct 2023
32
32
10
Nov 2023
21
21
9
Dec 2023
24
24
14
Jan 2024
28
29
12
Feb 2024
45
46
17
Mar 2024
21
22
21
Total
1770
1794
1125
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?